UBS AM’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.8M | Sell |
|
|||||
|
2025
Q2 | $24.3M | Buy |
|
|||||
|
2025
Q1 | $25.2M | Sell |
|
|||||
|
2024
Q4 | $11.3M | Buy |
|
|||||
|
2024
Q3 | $9.36M | Sell |
|
|||||
|
2024
Q2 | $7.17M | Buy |
|
|||||
|
2024
Q1 | $3.06M | Sell |
|
|||||
|
2023
Q4 | $4.06M | Buy |
|
|||||
|
2023
Q3 | $3.29M | Sell |
|
|||||
|
2023
Q2 | $2.89M | Hold |
|
|||||
|
2023
Q1 | $2.89M | Buy |
|
|||||
|
2022
Q4 | $2.64M | Sell |
|
|||||
|
2022
Q3 | $3.41M | Sell |
|
|||||
|
2022
Q2 | $3.9M | Sell |
|
|||||
|
2022
Q1 | $3.79M | Buy |
|
|||||
|
2021
Q4 | $2.96M | Buy |
|
|||||
|
2021
Q3 | $2.91M | Buy |
|
|||||
|
2021
Q2 | $3.03M | Buy |
|
|||||
|
2021
Q1 | $3.15M | Sell |
|
|||||
|
2020
Q4 | $3.72M | Buy |
|
|||||
|
2020
Q3 | $1.9M | Sell |
|
|||||
|
2020
Q2 | $1.85M | Buy |
|
|||||
|
2020
Q1 | $1.26M | Buy |
|
|||||
|
2019
Q4 | $955K | Sell |
|
|||||
|
2019
Q3 | $1.38M | Buy |
|
|||||
|
2019
Q2 | $817K | Sell |
|
|||||
|
2019
Q1 | $1.07M | Buy |
|
|||||
|
2018
Q4 | $1.06M | Buy |
|
|||||
|
2018
Q3 | $946K | Buy |
|
|||||
|
2018
Q2 | $1.02M | Buy |
|
|||||
|
2018
Q1 | $1.05M | Buy |
|
|||||
|
2017
Q4 | $1.03M | Buy |
|
|||||
|
2017
Q3 | $766K | Buy |
|
|||||
|
2017
Q2 | $454K | Sell |
|
|||||
|
2017
Q1 | $507K | Buy |
|
|||||
|
2016
Q4 | $120K | Sell |
|
|||||
|
2016
Q3 | $256K | Hold |
|
|||||
|
2016
Q2 | $215K | Hold |
|
|||||
|
2016
Q1 | $184K | Buy |
|
|||||
|
2015
Q4 | $173K | Hold |
|
|||||
|
2015
Q3 | $130K | Hold |
|
|||||
|
2015
Q2 | $209K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $87K | Hold |
|
|||||
|
2013
Q2 | $95K | Buy |
|